 6. Administration of any standard, non-adjuvanted influenza vaccine e.g. live attenuated trivalentquadrivalent inactivated influenza vaccine intranasal or split trivalentquadrivalent inactivated influenza vaccine by either intradermal or intramuscular IM route within 24 months prior to randomization and up to completion of the Day 21 visit; 